MARKET

ARCT

ARCT

Arcturus
NASDAQ

Real-time Quotes | Nasdaq Last Sale

13.25
-2.57
-16.25%
Closed 17:35 03/30 EDT
OPEN
15.94
PREV CLOSE
15.82
HIGH
16.27
LOW
13.03
VOLUME
273.42K
TURNOVER
--
52 WEEK HIGH
19.00
52 WEEK LOW
5.70
MARKET CAP
200.58M
P/E (TTM)
-5.5172
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ARCT and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 8 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average ARCT stock price target is 24.43 with a high estimate of 32.00 and a low estimate of 18.00.

EPS

ARCT News

More
  • Arcturus bullish on Duke system in Covid-19 vaccine development
  • seekingalpha · 3d ago
  • Arcturus' COVID-19 vaccine to benefit from Duke-NUS genetic correlation system
  • Seeking Alpha - Article · 3d ago
  • Arcturus COVID-19 Vaccine to Benefit from Duke-NUS Genetic Correlation System
  • GlobeNewswire · 3d ago
  • The Stock Market Has Tanked: What To Do Next
  • Seeking Alpha - Article · 03/19 18:30

Industry

Biotechnology & Medical Research
+4.00%
Pharmaceuticals & Medical Research
+4.75%

Hot Stocks

Symbol
Price
%Change

About ARCT

Arcturus Therapeutics Holdings Inc. is a ribonucleic acid (RNA) medicines company focused on liver and respiratory diseases. In addition to its internal messenger RNA (mRNA) platform, its lipid nanoparticle deliver system, LUNAR, enables multiple nucleic acid medicines. It is expertized in the discovery and development of RNA medicines, including in the production of RNA drug substance and nanoparticle-formulated drug product. It has a pipeline of seven drugs in the late-stage discovery and early-stage development out of which two are wholly-owned and five are pharma partnered programs. It is focused on applying its technologies to develop RNA medicines in multiple therapeutic approaches, which include mRNA, deoxyribonucleic acid (DNA), and replicon protein replacement for therapeutics and protein delivery for vaccines; small interfering RNA (siRNA), microRNA, and antisense oligonucleotides knockdown of genes overexpressed in disease; and CRISPR, TALEN and zinc finger proteins.
More

Webull offers kinds of Arcturus Therapeutics Ltd stock information, including NASDAQ:ARCT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ARCT stock news, and many more online research tools to help you make informed decisions.